Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer

Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer

New research: Blood stem cells can be involved in pathogenesis of CLL

New research: Blood stem cells can be involved in pathogenesis of CLL

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Zinc lozenges might reduce duration of common cold episodes by 40%

Zinc lozenges might reduce duration of common cold episodes by 40%

Stellacure to open umbilical cord blood stem cell company in Jordan

Stellacure to open umbilical cord blood stem cell company in Jordan

Scientists demonstrate how Modified Citrus Pectin enhances immune function

Scientists demonstrate how Modified Citrus Pectin enhances immune function

G-CSF therapy does not induce chromosomal instability in healthy stem cell donors

G-CSF therapy does not induce chromosomal instability in healthy stem cell donors

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

Gene therapy to combat leukemia

Gene therapy to combat leukemia

China Medical receives SFDA approvals for TOP2A and prostate cancer FISH detection kits

China Medical receives SFDA approvals for TOP2A and prostate cancer FISH detection kits

Cancer-causing fusion protein works by silencing tumor suppressor gene IL-2Rγ

Cancer-causing fusion protein works by silencing tumor suppressor gene IL-2Rγ

TrovaGene regains ownership of worldwide rights to transrenal technology

TrovaGene regains ownership of worldwide rights to transrenal technology

NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

Researchers clarify role of two proteins key to T-cell development

Researchers clarify role of two proteins key to T-cell development

New strategies for successful donor adult stem cell transplants in blood cancer patients

New strategies for successful donor adult stem cell transplants in blood cancer patients

Specific microRNA cluster could play a key role in retinoblastoma development

Specific microRNA cluster could play a key role in retinoblastoma development

Roadmap to overcome obstacles for using induced pluripotent stem cells

Roadmap to overcome obstacles for using induced pluripotent stem cells

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

Micromet second quarter total revenues increase to $7.1 million

Micromet second quarter total revenues increase to $7.1 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.